breast cancer

February 6, 2025

Waddell Walker Hancock Cancer Discovery Fund names two more scholars 

The funds will support Justin Balko’s research on breast cancer and Kathleen DelGiorno’s research on pancreatic cancer.

By Tom Wilemon
(iStock)
January 15, 2025

Study in multiancestry populations uncovers new insights into breast cancer genetics 

The study identified 332 independent association signals for breast cancer risk, including 131 signals not previously reported.

By Tom Wilemon
(iStock)
January 8, 2025

Worldwide experts release clinical recommendations for management of ATM cancer risk 

Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.

By Tom Wilemon
December 10, 2024

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.

By Tom Wilemon
(iStock)
September 17, 2024

Protocol improves follow-up for women at high risk for breast cancer 

Before the protocol, every patient underwent a Breast Cancer Risk Assessment Tool evaluation, yet there was no established protocol for sharing the results.

By Tom Wilemon
Galen Perdikis, MD, left, and G. Patrick Maxwell, MD.
June 3, 2024

Dedication to advancing breast reconstruction surgery for patients links Perdikis, Maxwell

Perdikis now holds the recently established G. Patrick Maxwell, M.D. Chair of the Department of Plastic Surgery at Vanderbilt University Medical Center.

By Lucie Alig
May 30, 2024

Speakers share history of hereditary cancers at scientific retreat 

Speakers at the Vanderbilt-Ingram Cancer Center 25th Annual Scientific Retreat detailed the history of hereditary cancer discoveries and gave overviews about ongoing research. 
By Tom Wilemon
May 14, 2024

Breast cancer risk variants identified for women of African ancestry

A study led by researchers from Vanderbilt-Ingram Cancer Center sheds light on some of the genetic variants that make breast cancer more deadly for women of African ancestry and significantly reduces the disparity in knowledge for assessing their genomic risk factors.
By Tom Wilemon
March 8, 2024

Scalp cooling allows woman to keep hair during chemotherapy

The Food and Drug Administration first granted marketing approval for the DigniCap system for patients with breast cancer in 2015, then in 2017 the FDA expanded the authorization, making it the first cooling cap cleared for use in cancer patients with solid tumors, such as breast cancer, ovarian cancer and colorectal cancer.
By Tom Wilemon
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
By Tom Wilemon
June 8, 2023

An image of cancer treatment response

An MRI method developed by Vanderbilt researchers uses imaging data to derive cell size and could be added to clinical practice for better monitoring of breast cancer treatment response.
By Sarah E. Glass
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.
By Tom Wilemon
1 2 3 … 11